The decreased expression of downregulated DEGs enriched in Ca2+ metabolism, including CXCL10, CXCL13, and PDE1C, as identified in this study could play a role in obesity and its associated complications by lowering Ca2+ levels. Here, CXCL13 is linked to obesity disorder.